Dami Xiaomi

formerly Dami & Xiaomi

Dami Xiaomi is a healthcare company in Shenzhen, China, founded in 2014. It has raised $62.6M across 5 rounds, most recently a $42.0M Series D in July 2022.

大米和小米-儿童小儿幼儿孩子自闭症/孤独症/语言/社交/专注力/学习等障碍的特殊需要儿童训练康复中心

Headquarters
Shenzhen
Employees
201–500
Founded
2014
Business Model
B2C
Website
dmhxm.com
Total Funding
$62.6M
Last Round
$42.0M Series DJul 2022
Rounds
5

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 5 funding rounds and 5 investors for this company. The full record is or through the API.

About

Dami Xiaomi (大米小米) is a China-based platform and service organization dedicated to early intervention, rehabilitation, and education for children with autism spectrum disorder (ASD) and other developmental disorders. Founded in 2014 and headquartered in Shenzhen, Guangdong, the company operates as one of China's leading for-profit autism intervention service providers, offering structured therapeutic programs and educational resources for children and their families. The platform combines in-person intervention centers with digital tools, and has explored integrating large AI models into its autism rehabilitation programs to expand service reach and improve outcomes. Dami Xiaomi has received backing from impact-oriented investors including ABC Impact, which highlighted it as a notable investment in sustainable finance reporting.

Summary

It lists 201–500 employees. It has raised $62.6M in total across 5 rounds, most recently a $42.0M Series D round in Jul 2022. Investors include Grand Flight Investment, ABC Impact and OrbiMed.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series DSeries DJul 2022
$42.0M

Sign up to see all 5 events

Funding: Series A through Series D. Amounts, valuations, and investors where available.

Investors

Similar Companies

MultiPlanIPO

Healthcare cost management company providing data analytics and network-based payment solutions t...

New York, United States1001–5000Healthcare
Private EquityTotal funding$7.4BMar 2014
The Bountiful CompanyAcquired

American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...

Ronkonkoma, United States1001–5000Healthcare, Retail
Private EquityTotal funding$7.0BJul 2017
Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
OneOncologyAcquired

OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...

Nashville, United States1001–5000Healthcare, Data & Analytics
Extension RoundTotal funding$5.1BDec 2025
Canopy Growth Corporation Common SharesIPO

World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...

Smiths Falls, Canada1001–5000Healthcare
Corporate RoundTotal funding$4.5BJan 2024
Inizio

Inizio helps health and life sciences clients realize product potential through deep expertise, g...

New York, United States10001+Healthcare
Venture RoundTotal funding$4.4B

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Dami Xiaomi on Indexed.vc
<a href="https://indexed.vc/companies/dami-xiaomi"><img src="https://indexed.vc/api/badge/company/dami-xiaomi" alt="Dami Xiaomi on Indexed.vc" width="260" height="76" /></a>